International Network of VENous Thromboembolism Clinical Research Networks

REMAP-ATTACC

Antithrombotic Therapy to Ameliorate Complications of COVID-19

Registration:

NCT04372589

Sponsors:

University of Manitoba

Collaborator: University Health Network, Toronto

Status:

Recuiting

Design

A prospective, open-label, randomized, multicentre, adaptive clinical trial

Participating Sites

CanVECTOR logo

Lead Network:

CanVECTOR
Flag of Canada

Countries:

Canada,

Lead Investigators

Dr. Ryan Zarychanski, MD, MSc

rzarychanski@cancercare.mb.ca

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.